Apyx Medical Corporation

NASDAQ:APYX

Medical - Devices

Healthcare
$2.49 -1.90%

-$0.08 today

Market cap
$104.89M
Beta
1.39
P/E (TTM)
-19.0
EPS (TTM)
-$0.22
52W Low $1.59High $5.08

Volume 0.19M

Average 0.18M

APYX Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Apyx Medical CorporationNASDAQ: APYX

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses declines year over year

Q1 FY2026 operating expenses of $5.58M fell 35.9% year over year, ahead of the -43.7% change in trailing-twelve-month operating expenses. Over 3 fiscal years it compounded at -21.5% a year.

Context

  • Operating expenses amounted to 48.2% of revenue in FY2025, down 52.0 pp from a year earlier.
  • Operating expenses increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -35.9% holds above the trailing-twelve-month pace of -43.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.58M+376.0% QoQ
Last fiscal yearDec 2025
$25.48M-47.1% YoY
LTMMar 2026
$22.35M-43.7% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-35.9%——
1 year-47.1%——
3-year CAGR-21.5%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
25.48M USD
Year-over-year change
-47.1%
4-year CAGR
-14.7%

Operating Expenses vs competitors

How APYX compares with its peers on the latest reported figures

  • APYX's LTM Mar 2026 operating expenses of $22.35M is the 7th highest of the 8 companies compared; the peer median is $47.21M.
  • Its year-over-year change of -43.7% is the lowest of 8, against a peer median of +5.1%.
  • Operating expenses amounts to 40.0% of revenue for APYX, versus a peer median of 146.3%.
APYX Competitors Peer median
Operating Expenses for APYX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RCELAVITA Medical, Inc.LTM Mar 2026$98.38M -12.5%+21.7%136.0%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$72.7M -7.6%+25.6%59.6%
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$53.85M +9.6%+0.2%156.6%
LUCDLucid Diagnostics Inc.LTM Mar 2026$47.21M +5.1%-4.0%919.6%
SERASera Prognostics, Inc.LTM Mar 2026$36.51M -0.8%-7.3%64043.9%
VANIVivani Medical, Inc.LTM Mar 2026$27.68M +11.1%+8.5%—
APYXApyx Medical CorporationLTM Mar 2026$22.35M -43.7%-21.5%40.0%
PDEXPro-Dex, Inc.LTM Mar 2026$9.93M +18.0%+3.3%13.3%
Peer median (excluding APYX) $47.21M+5.1%+3.3%146.3%

Competitors are the stored peer set for APYX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue48.52M44.51M52.35M48.1M52.84M
Cost of Revenue14.92M15.38M18.59M18.74M33.81M
Gross Profit33.6M29.13M33.76M29.36M19.03M
Gross Margin69.3%65.4%64.5%61.0%36.0%
Research & Development4.32M4.54M4.84M5.08M3.37M
Selling, General & Admin43.73M48.15M48.87M43.13M36.12M
Operating Expenses48.05M52.69M51.02M48.21M25.48M
Depreciation & Amortization903K890K692K599K655K
EBITDA(13.91M)(22.01M)(18.11M)(16.8M)(4.59M)
EBITDA Margin-28.7%-49.4%-34.6%-34.9%-8.7%
Operating Income(14.45M)(23.56M)(17.26M)(18.85M)(6.45M)
Operating Margin-29.8%-52.9%-33.0%-39.2%-12.2%
Interest Income11K157K921K1.61M1.11M
Interest Expense10K15K2.48M5.91M5.59M
Other Income / Expenses(372K)651K(4.02M)(4.46M)(4.39M)
Income Before Tax(14.82M)(22.91M)(21.28M)(23.31M)(10.84M)
Pre-Tax Margin-30.5%-51.5%-40.7%-48.5%-20.5%
Income Tax Expense380K367K(2.43M)252K270K
Net Income(15.17M)(23.18M)(18.71M)(23.46M)(11.21M)
Net Margin-31.3%-52.1%-35.7%-48.8%-21.2%
EPS (Basic)(0.44)(0.67)(0.54)(0.66)(0.27)
EPS (Diluted)(0.44)(0.67)(0.54)(0.66)(0.27)
Weighted Avg Shares34.33M34.52M34.62M35.54M42.16M
Weighted Avg Shares (Diluted)34.33M34.52M34.62M35.54M42.16M

Apyx Medical Corporation

NASDAQ:APYX

Intrinsic Alpha fair value

Locked

Current Price

$2.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.